Signaling Interactions in the Adrenal Cortex

The major physiological stimuli of aldosterone secretion are angiotensin II (AII) and extracellular K⁺, whereas cortisol production is primarily regulated by corticotropin (ACTH) in fasciculata cells. AII triggers Ca²⁺ release from internal stores that is followed by store-operated and voltage-dependent Ca²⁺ entry, whereas K⁺-evoked depolarization activates voltage-dependent Ca²⁺ channels. ACTH acts primarily through the formation of cAMP and subsequent protein phosphorylation by protein kinase A. Both Ca²⁺ and cAMP facilitate the transfer of cholesterol to mitochondrial inner membrane. The cytosolic Ca²⁺ signal is transferred into the mitochondrial matrix and enhances pyridine nucleotide reduction. Increased formation of NADH results in increased ATP production, whereas that of NADPH supports steroid production. In reality, the control of adrenocortical function is a lot more sophisticated with second messengers crosstalking and mutually modifying each other’s pathways. Cytosolic Ca²⁺ and cGMP are both capable of modifying cAMP metabolism, while cAMP may enhance Ca²⁺ release and voltage-activated Ca²⁺ channel activity. Besides, mitochondrial Ca²⁺ signal brings about cAMP formation within the organelle and this further enhances aldosterone production. Maintained aldosterone and cortisol secretion are optimized by the concurrent actions of Ca²⁺ and cAMP, as exemplified by the apparent synergism of Ca²⁺ influx (inducing cAMP formation) and Ca²⁺ release during response to AII. Thus, cross-actions of parallel signal transducing pathways are not mere intracellular curiosities but rather substantial phenomena, which fine-tune the biological response. Our review focuses on these functionally relevant interactions between the Ca²⁺ and the cyclic nucleotide signal transducing pathways hitherto described in the adrenal cortex.

Introduction

The adrenal cortex contains three zones, of which glomerulosa secretes the mineralocorticoid aldosterone, fasciculata synthesizes the glucocorticoid cortisol (or corticosterone in rodents), whereas the reticularis produces androgens [reviewed in Ref. (1)]. Aldosterone, acting on the distal nephron, augments Na⁺ reabsorption as well as K⁺ and H⁺ excretion. Through changes in sodium balance, it influences the extracellular fluid space and blood pressure, and its importance in cardiovascular, renal, and inflammatory diseases has also been recognized (2–4). Cortisol, among other things, controls intermediary metabolism, modulates immune responses, and is essential for the resistance of the organism to noxious stimuli. Adrenal androgens exert important anabolic effects in females and have substantial clinical significance in adrenal pathologies.

Sodium and/or fluid depletion, hemodynamic changes, and hyperkalemia stimulate aldosterone secretion. When fluid loss is severe, ACTH synergizes with angiotensin II (AII) in stimulating glomerulosa cells. During hypervolemia, atrial natriuretic peptide (ANP) inhibits aldosterone secretion [for reviews, see Ref. (5, 6)]. Cortisol production is governed by ACTH. The regulation of ACTH secretion and the signaling in zona reticularis (7) are beyond the scope of this review.

Classical Signaling Pathways in the Adrenal Cortex

Signaling Pathways in Glomerulosa Cells

The major signaling pathways of ACTH, K⁺, and AII, termed “classical” here have been described in several reviews [e.g., Ref. (5, 6, 8, 9)] and are only briefly summarized below.

ACTH binds to the melanocortin-type receptor MC2R, which activates adenylyl cyclase (AC) via the heterotrimeric G-protein G_s (10, 11), and subsequent cAMP formation activates protein kinase A (PKA). PKA then phosphorylates and induces the hormone-sensitive lipase (previously “cholesterol ester hydrolase”) (12) as well as the steroidogenic acute regulatory protein (StAR), the protein transporting cholesterol into the mitochondria (13, 14). As a result of these, the steroid precursor cholesterol is released from lipid droplets and transported to side-chain cleavage by CYP11A1, located in the inner mitochondrial membrane. This causes the stimulation of adrenal steroidogenesis.

Extracellular K⁺ and AII act by generating cytosolic Ca²⁺ signal. Depolarization induced by physiological elevations of [K⁺] activates T-type voltage-dependent Ca²⁺ channels the current of which was detected in rat (15–17), bovine (16, 18, 19), and human glomerulosa cells (20). Concomitant cell swelling evoked by K⁺ also enhances this T-type current (21, 22).

The unique sensitivity of glomerulosa cells to K⁺ (6, 23, 24) may be attributed to their high permeability to K⁺ (19, 25–28) and the function of the T-type channel Ca_v3.2. The channel’s subunit α_1H is expressed in rat, murine, and bovine glomerulosa cell (29, 30). In view of the very negative membrane potential of isolated glomerulosa cells (27, 31), basal Ca²⁺ influx was attributed to a steady-state window current (19, 32). The control of Ca_v3.2 in glomerulosa cells has recently been analyzed in murine adrenal slices (30), in which cells had a mean resting potential of −82 mV. Spontaneous membrane potential oscillations generated by Ca_v3.2 were observed between −87 and −75 mV. Increasing [K⁺] up to 5 mM depolarized the membrane and increased oscillation frequency and peak amplitudes, whereas the increased frequency upon AII stimulation was most probably due to a G_i-mediated shift in the voltage dependence of channel activation toward more negative potentials (33). In either cases, the ensuing Ca²⁺ signal (via CaMKII and p42/44 MAP kinase) acts on hormone-sensitive lipase (34) and StAR (13, 35, 36) [similarly to the actions of PKA (37)].

Angiotensin II stimulates aldosterone secretion after binding to AT₁ receptors (AT1Rs) (38–40). Acting via the G-protein G_q and phospholipase C_β, it induces the formation of inositol 1,4,5-trisphosphate (IP₃) (41–43) which, through specific receptors [IP3Rs (44–46)] generates Ca²⁺ signal. Out of the three receptor isoforms expressed in glomerulosa cells (47), the dominant IP₃R1 exhibits the greatest affinity for IP₃. The initial Ca²⁺ release is followed by Ca²⁺ influx (48, 49) through store-operated (50, 51) and later via T-type Ca²⁺ channels (18, 33) [but see Ref. (52)]. In isolated rat glomerulosa cells, AII-induced T-type current is activated by depolarization (19) brought about by the inhibition of the Na⁺/K⁺ pump (53) and by the two-pore domain K⁺ channel TASK (25, 54). In murine cells maintained in situ, T-current is enhanced by a G_i-mediated increase in the frequency of oscillating action potentials (30, 33).

Angiotensin II inhibits L-type current (55) and thus attenuates Ca²⁺ signals evoked by high [K⁺] (56, 57). This effect of the peptide is mediated by the G-protein G_i, expressed in glomerulosa cells (55, 58).

Due to space limits, this review does not deal with diacylglycerol – protein kinase C (PKC), lipoxygenase, and MAPK pathways [reviewed, e.g., in Ref. (6)].

Signaling in Fasciculata Cells

The physiological stimulus of glucocorticoid synthesis and secretion by fasciculata cells is ACTH, acting via MC2R receptors and cAMP. The mode of cAMP action is identical to that described above for glomerulosa cell [for review, see Ref. (59)].

ACTH action on fasciculata cells requires Ca²⁺. As observed already in the 70s, ACTH induces membrane potential changes (60) due mainly to Ca²⁺ influx (61). Both T-type (Ca_v3.2) and L-type (Ca_v1.3 and a non-identified) isoforms were characterized in bovine fasciculata cells, and their participation in ACTH- and AII-stimulated cortisol secretion was demonstrated (62). We are not aware of data on Ca²⁺ channels in rat and native human fasciculata cells; however, the observation that rat fasciculata cells were unresponsive to 13 mM K⁺ (23) indicates the lack of T-type Ca²⁺ channels. The resting membrane potential in bovine fasciculata cells is set by the background K⁺ channel bTREK-1 (63), whereas the TASK-3 background K⁺ channel, characteristic for rat glomerulosa cell (26), is undetectable in bovine fasciculata cells (64).

Albeit AT1R is expressed in human, bovine, and ovine fasciculata cells (65–67) data whether AII alone stimulates cortisol secretion are conflicting (62, 68–70). Rat fasciculata cells do not express detectable amounts of AT1R (71–73) [but see Ref. (74)] or inositol 1,4,5-trisphosphate receptor (IP3R) mRNA (47) and, accordingly, AII does not stimulate steroid production in these cells (23, 74, 75).

The expression of AT1R in fasciculata cells and the stimulation of cortisol secretion by the peptide raise the question whether AII plays any role in the control of cortisol secretion in man. In lack of comprehensive studies, we hypothesize that in stress situations, stimulation of fasciculata cells by AII may contribute to the stimulatory action of ACTH. On the other hand, in case of long-term high AII levels, cortisol secretion is maintained at resting level by the feed-back control of ACTH secretion.

The human adrenocortical cancer-derived H295R cell, a widely used model for studying steroid production, does not express either MC2R receptors (76) or Ca_v3.2 T-type Ca²⁺ channels (30) [but see Ref. (77)]. Not surprisingly, these cells are insensitive to ACTH and respond to K⁺ at supraphysiological concentrations only (78).

Interaction of Signaling Pathways in Adrenocortical Cells

(Auto)Regulation of Ca²⁺ Metabolism by Ca²⁺

The formation, metabolism, and the action of IP₃ all depend on cytosolic [Ca²⁺] ([Ca²⁺]_c). Phospholipase C_γ, generating IP₃ from PIP₂ (79) and the IP₃ metabolizing IP₃-3 kinase are both activated by Ca²⁺ (80–82). High [Ca²⁺]_c may reduce IP₃ binding (83), whereas elevation of [Ca²⁺]_c up to ~300 nM increases the sensitivity of IP₃R1 to IP₃ [reviewed in Ref. (6)]. These characteristics play an important role in the oscillatory pattern of Ca²⁺ release. IP₃R phosphorylation by PKA, PKC, or CaMKII enhances Ca²⁺ release, while calcineurin decreases this phosphorylation state (84). Also, calcium–calmodulin activates the plasmalemmal Ca ATPase (85) and inhibits the Na⁺/K⁺ ATPase (86, 87), the latter resulting in depolarization and Ca²⁺ influx through T-type channels (see Signaling Pathways in Glomerulosa Cells).

Effects of Ca²⁺ on Cytosolic cAMP

Early reports on K⁺-evoked cAMP formation suggested a role for Ca²⁺ in the activation of AC (88, 89). Maintained secretagogue effect of ACTH in rat glomerulosa (90) and bovine fasciculata cells is also Ca²⁺-dependent (62) with calcium–calmodulin affecting primarily the formation of cAMP (91). In fact, in bovine cells, the effect of ACTH on cAMP formation correlates to extracellular [Ca²⁺] (92), and ACTH-induced cAMP formation is potentiated by AII in the presence of Ca²⁺ only (69).

Nevertheless, conflicting data were reported concerning the effect of AII on cAMP formation in bovine adrenocortical cells (69, 93–95). Reduced cAMP formation was reported in AII-stimulated rat glomerulosa cells (96, 97), whereas enhanced cAMP formation was observed in the human H295R cell (98). In this respect, the Ca²⁺ sensitivity of different transmembrane adenylyl cyclase isoforms (99, 100) should be considered. The Ca²⁺-activatable isoform AC1 is expressed in human glomerulosa and fasciculata cells (99); the Ca²⁺/calmodulin-activatable AC3 was found in human (99), rat (101), and bovine (69) glomerulosa cells. Ca²⁺-inhibited isoforms (AC5 and AC6) were detected in human (99) and rat glomerulosa cells (102). It should also be kept in mind that Ca²⁺-activatable AC isoforms are more responsive to store-operated Ca²⁺ entry than to Ca²⁺ release. This phenomenon is due to the colocalization of Ca²⁺ activatable AC isoforms and store-operated Ca²⁺ channels in plasmalemmal lipid rafts (103) and may account for the delayed cAMP response to AII (98).

After the description of G_i in rat glomerulosa cells (58), the reported inhibition of AC by AII was attributed to this inhibitory G-protein (55, 95). Summarizing, the cell-type differences in the effect AII on AC may be attributed to G_i density and the ratio of the various AC isoforms.

The Ca²⁺-modified signaling pathways are summarized in Figure 1.

FIGURE 1

Figure 1. Effects of Ca²⁺ on cytosolic cAMP in glomerulosa cells. Positive modulations are shown with green arrows and negative effects are shown with red blunted arrows. Black arrows indicate substance transport. Ca_v1.3, L-type voltage-dependent Ca²⁺ channel; Ca_v3.2, T-type voltage-dependent Ca²⁺ channel; ANP, atrial natriuretic peptide; AII, angiotensin II; AT1R, angiotensin II receptor type 1, G_i and G_q, heterotrimeric G-proteins; PIP₂, phosphatidyl inositol 1,4,5-trisphosphate; TASK, KCNK3 or KCNK9-type K⁺ channel; AC, transmembrane adenylyl cyclase; ER, endoplasmic reticulum; IP₃, inositol 1,4,5-trisphosphate; IP3R, IP₃ receptor; HSL, hormone-sensitive lipase; StAR, steroidogenic acute regulatory protein.

Effects of cAMP on Ca²⁺ Signaling

ACTH or cell-permeable cAMP analogs may induce a sustained Ca²⁺ signal after a lag time of a few minutes as was shown in rat (104), bovine (92), and human glomerulosa cells (105), as well as in H295R cells (106). Several molecular interactions may warrant such an effect. PKA phosphorylates L-type Ca²⁺ channels (105, 107) [but see Ref. (108)], the ensuing Ca²⁺ current activates phospholipase C_δ, and the generated IP₃ induces Ca²⁺ release from the endoplasmic reticulum (ER). In addition, PKA also phosphorylates and activates IP₃R1 [reviewed in Ref. (6)]. In fact, ACTH evokes a small phosphoinositide response (109) and PKC activation (110) in rat glomerulosa cells. By the same token, 8Br-cAMP enhanced AII-induced IP₃ formation in bovine cells (111). Taken together, cAMP and its downstream effectors may enhance both Ca²⁺ influx and Ca²⁺ release in the adrenals.

The cAMP-modified signaling pathways are summarized in Figure 2.

FIGURE 2

Figure 2. Effects of cAMP on Ca²⁺ signaling in glomerulosa cells. Positive modulations are shown with green arrows and negative effects are shown with red blunted arrows. Black arrows indicate substance transport. Ca_v1.3, L-type voltage-dependent Ca²⁺ channel; Ca_v3.2, T-type voltage-dependent Ca²⁺ channel; ANP, atrial natriuretic peptide; AII, angiotensin II; AT1R, angiotensin II receptor type 1, G_i and G_q, heterotrimeric G-proteins; AC, transmembrane adenylyl cyclase; ER, endoplasmic reticulum; IP3R, IP₃ receptor; HSL, hormone-sensitive lipase; StAR, steroidogenic acute regulatory protein; ACTH, corticotropin; MC2R, melanocortin receptor type 2, PDE, cAMP phosphodiesterase; AMP, adenosine monophosphate.

Signaling Modulation by cGMP

Cyclic GMP is formed after the activation of ANP receptors. The nucleotide reduces T-type Ca²⁺ current (112) and inhibits the AC (113). In addition, cGMP activates PDE2A (114–116), one of phosphodiesterase isozymes identified in adrenocortical cells [reviewed by Vezzosi and Bertherat (117)]. By these actions, ANP reduces basal and stimulated aldosterone secretion (112).

Synergistic Effects of Ca²⁺ Release and Ca²⁺ Influx

Moderate hyperkalemia increases the sensitivity and the maximal aldosterone response to AII (118–120). Potassium (4–8 mM) potentiates the secretory response to thapsigargin (evoking net Ca²⁺ release from the ER), whereas the secretory effects of thapsigargin and AII (300 pM) are additive only (119). When net Ca²⁺ release was induced with Ni²⁺, an inhibitor of microsomal Ca²⁺ uptake, the aldosterone response to physiological concentrations of K⁺ was again potentiated (121). These observations indicate that Ca²⁺ release and influx act in synergism on aldosterone secretion.

The synergism between Ca²⁺ release and influx may be explained by the formation of microdomains. Increased subplasmalemmal [Ca²⁺] (formed around the orifice of Ca²⁺ channels) may activate e.g., Ca²⁺-dependent AC isoforms and may induce specific gene expression (122, 123). On the other hand, Ca²⁺ release into the perinuclear space may turn on Ca²⁺-dependent nuclear genes and enhance NAD(P)H formation in ER-vicinal mitochondria (see Ca²⁺ Signal and Mitochondrial Function). In addition, the reduction in exchangeable Ca²⁺ pool during exposure to AII (124) may be counterbalanced by concomitant Ca²⁺ influx.

Angiotensin II-induced initial IP₃ peak is followed by sustained suprabasal IP3 formation (41). Li⁺ inhibits the resynthesis of phosphoinositides and precludes the maintained formation of IP₃, and thus attenuates the post-initial phase of AII-induced (but not ACTH-induced) aldosterone output of glomerulosa cells (125). This indicates that sustained suprabasal IP₃ formation, Ca²⁺ release and, probably, store-operated Ca²⁺ entry all support long-lasting aldosterone secretion.

Effects of Convergent Signaling on Gene Expression

Both Ca²⁺ and cyclic nucleotide signaling affect the transcriptome of adrenocortical cells (126, 127). Complex transcriptional or epigenetic (128) changes during adrenal zonation, remodeling, and neoplastic transformation are beyond the scope of this study [for review, see, e.g., Ref. (129, 130)]. Instead, we focus on instances where gene expression is modulated by parallel signal transducing pathways. One illustrative example of such an interplay involves the transcriptional regulation of hormone-sensitive lipase and StAR, both of which are induced by the cAMP-PKA (12–14) and by the Ca²⁺ pathway (13, 34–36). Along similar lines, Ca²⁺ and cAMP, through overlapping cis regulatory elements, synergistically induce the transcription of aldosterone synthase (CYP11B2) (131) and (as observed in non-adrenal cells) the mitochondrial Ca²⁺ uniporter (MCU, see below) (132). Transcription of type I 3β-hydroxysteroid dehydrogenase (HSD3B1), expressed predominantly in the human zona glomerulosa (133), can be induced by AII but not by K⁺ (134). A plausible explanation is that only AII [in part via PKC (135, 136)] recruits the nuclear receptor subfamily 4 (NGFI-B), which is also necessary for the induction of HSD3B1. In contrast, both AII and K⁺ induce CYP11B2 expression via the Ca²⁺/CaMK and MAP kinase pathways (137).

In vascular smooth muscle cells, both G_s- and G_q-initiated signaling dampen the expression of AT1R through mRNA destabilization (138). Interestingly, to carry out this mRNA degradation, the pathways partially converge on PKA (139). An effect closely reminiscent of such a convergence was observed in H295R cells where forskolin, db-cAMP, and AII all brought about a rapid drop in AT1R message levels. [Nevertheless, long-term AT1R repression was induced with forskolin/db-cAMP only (140).]

Ca²⁺ Signal and Mitochondrial Function

Calcium activates three dehydrogenases in suspended or homogenized mitochondria (141). Ca²⁺-dependent mitochondrial NADH and NADPH (NAD(P)H) formation in living cells was first demonstrated in K⁺-stimulated glomerulosa cells (142). Similar response to AII and vasopressin was also reported (143, 144). The significance of increased NADH and ensuing ATP production (145) in any biological response is obvious, whereas NADPH is a cofactor of steroid biosynthesis (1). Noteworthy, the spatial and temporal pattern of AII-induced cytosolic Ca²⁺ signal depends on mitochondrial metabolism (78).

The primary event in the mitochondrial response to a cytosolic Ca²⁺ signal is the transfer of the ion into the mitochondrial matrix (146–149). Ca²⁺ transport occurs through the MCU complex, the velocity of which is a sigmoid function of [Ca²⁺]_c due to the allosteric control of the MCU channel by the regulatory subunits MICU1 and MICU2 [reviewed in Ref. (150)]. IP₃-induced Ca²⁺ release from the ER generates high-Ca²⁺ microdomains between the ER and mitochondria and allows for mitochondrial Ca²⁺ uptake by the low-Ca²⁺-affinity MCU (151). However, the mitochondria of glomerulosa cells are uniquely sensitive to Ca²⁺ (152) and influx-induced low-Ca²⁺ signals are also effective in elevating mitochondrial [Ca²⁺] ([Ca²⁺]_m) (153). This responsiveness may be essential for maintained aldosterone secretion in response to long-lasting hyperkalemia, characterized by small elevation of [Ca²⁺]_c.

Increased [Ca²⁺]_m and the ensuing NAD(P)H formation play an essential role in the stimulation of aldosterone production. Targeted mitochondrial expression of a Ca²⁺ binding protein reduces both [Ca²⁺]_m and NAD(P)H and ensuing aldosterone production in response to AII (154). The opposite, increased mitochondrial Ca²⁺ uptake after the knockdown of p38 MAPK or the silencing of mitochondrial protein OPA1 results in increased NAD(P)H formation and enhanced aldosterone production (155).

A recently recognized and biologically significant action of Ca²⁺ signaling is the formation of cAMP in mitochondria. In addition to the nine isoforms of transmembrane AC, a soluble isoform (sAC) was prepared from testis (156). Its activity is not influenced by forskolin or G-proteins but increased by bicarbonate (157) and Ca²⁺ (158). The expression of sAC in the mitochondrial matrix together with a degrading mechanism sensitive to phosphodiesterase 2A inhibitors were recently described in HeLa cells (159, 160). The activity of intramitochondrial sAC increased in response to mitochondrial Ca²⁺ signal in HeLa and CHO cells and in rat cardiomyocytes (161). Importantly, mitochondrial cAMP (mt-cAMP) supported ATP formation (160, 161).

The sAC is also expressed in H295R adrenocortical cells, and it is found in the particulate fraction predominantly. In these cells, AII-induced mitochondrial Ca²⁺ signal increased the formation of mt-cAMP, and this response was enhanced by the PDE2A inhibitor EHNA. Mitochondrial cAMP signaling was attenuated with the sAC inhibitor 2-OH-estradiol, after silencing of the sAC gene and by the buffering of mitochondrial Ca²⁺ by S100G protein. All these maneuvers also attenuated aldosterone production, showing the cell-type-specific significance of mt-cAMP for the first time (98).

Conclusion

Adrenocortical steroid production is under the control of both Ca²⁺ signaling and cyclic nucleotide metabolism. Importantly, these intracellular pathways are rarely, or probably never, independent. As postulated by Berridge in 1975 (162), cAMP and Ca²⁺ signaling may be antagonistic or synergistic in nature and, as hopefully accentuated by this review, the adrenal cortex is no exception to this rule. As shown in Figures 1 and 2, the aforementioned signal transducing pathways have the potential to interact at a number of points and levels of signaling. However, it needs to be stressed that these potential interactions are not enforced all at once but, instead, may be limited temporally and spatially (e.g., to signaling microdomains). Also, significant variance in the expression pattern and intensity of the relevant signaling molecules is to be expected depending on species and on the stimuli the organism is concurrently exposed to.

In spite of the interspecies differences and of the incongruences in some experimental data, it is probably safe to conclude that an adequate biological response necessitates the intricate interplay of parallel signaling pathways. That is to say that, e.g., in glomerulosa cells, sustained aldosterone response evoked by long-lasting tonic stimuli will be satisfactory only if the Ca²⁺ release/influx is accompanied by the sufficient formation of cAMP. Albeit the secretagogues AII and K⁺ invoke predominantly Ca²⁺ signaling and the effects of ACTH are mediated chiefly by cAMP, the increase of both factors at the same time may potentiate the final response. Thus, the separate intracellular pathways need not be activated to the same extent but nevertheless have to be recruited simultaneously for a sufficient steroid production to follow.

Author Contributions

AS and GS compiled the literary data and wrote the manuscript. Data on the control of expression have been discussed with LH.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

The authors were supported by the Hungarian Academy of Sciences and by the Hungarian National Science Foundation (OTKA NK100883). GS was also supported by the János Bolyai Research Scholarship of the Hungarian Academy of Sciences. The artwork of the figures was kindly prepared by Ms. Anna Szilágyi.

References

1. Vinson GP, Whitehouse B, Hinson J. The Adrenal Cortex. Englewood Cliffs, NJ: Prentice Hall (1992). p. 65–139.

Google Scholar

2. Gomez-Sanchez CE. Non renal effects of aldosterone. Steroids (2014) 91:1–2. doi:10.1016/j.steroids.2014.10.003

CrossRef Full Text | Google Scholar

3. Pacurari M, Kafoury R, Tchounwou PB, Ndebele K. The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflam (2014) 2014:689360. doi:10.1155/2014/689360

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Auchus RJ. Classics in cardiovascular endocrinology – aldosterone action beyond electrolytes. Endocrinology (2016) 157(2):429–31. doi:10.1210/en.2015-2061

CrossRef Full Text | Google Scholar

5. Bollag WB. Regulation of aldosterone synthesis and secretion. Compr Physiol (2014) 4:1017–55. doi:10.1002/cphy.c130037

CrossRef Full Text | Google Scholar

6. Spät A, Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev (2004) 84:489–539. doi:10.1152/physrev.00030.2003

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Parker LN. Control of adrenal androgen secretion. Endocrinol Metab Clin North Am (1991) 20(2):401–21.

PubMed Abstract | Google Scholar

8. Hattangady NG, Olala LO, Bollag WB, Rainey WE. Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol (2012) 350:151–62. doi:10.1016/j.mce.2011.07.034

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev (2004) 25:947–70. doi:10.1210/er.2003-0030

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Albano JDM, Brown BL, Ekins RP, Tait SAS, Tait JF. The effects of potassium, 5-hydroxytryptamine, adrenocorticotropin and angiotensin II on the concentration of adenosine 3’:5’-cyclic monophosphate in suspensions of dispersed rat adrenal zona glomerulosa and zona fasciculata cells. Biochem J (1974) 142:391–400. doi:10.1042/bj1420391

CrossRef Full Text | Google Scholar

11. Grahame-Smith DG, Butcher RW, Ney RL, Sutherland EW. Adenosine 3’,5’-monophosphate as the intracellular mediator of the action of adrenocorticotropic hormone on the adrenal cortex. J Biol Chem (1967) 242:5535–41.

Google Scholar

12. Holm C, Osterlund T, Laurell H, Contreras JA. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr (2000) 20:365–93. doi:10.1146/annurev.nutr.20.1.365

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Kim YC, Ariyoshi N, Artemenko I, Elliott ME, Bhattacharyya KK, Jefcoate CR. Control of cholesterol access to cytochrome P450scc in rat adrenal cells mediated by regulation of the steroidogenic acute regulatory protein. Steroids (1997) 62:10–20. doi:10.1016/S0039-128X(96)00153-5

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Rone MB, Fan J, Papadopoulos V. Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim Biophys Acta (2009) 179:646–58. doi:10.1016/j.bbalip.2009.03.001

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Durroux T, Gallo-Payet N, Payet MD. Three components of the calcium current in cultured glomerulosa cells from rat adrenal gland. J Physiol (1988) 404:713–29. doi:10.1113/jphysiol.1988.sp017315

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Quinn SJ, Brauneis U, Tillotson DL, Cornwall MC, Williams GH. Calcium channels and control of cytosolic calcium in rat and bovine zona glomerulosa cells. Am J Physiol (1992) 262:C598–606.

PubMed Abstract | Google Scholar

17. Várnai P, Osipenko ON, Vizi ES, Spät A. Activation of calcium current in voltage-clamped rat glomerulosa cells by potassium ions. J Physiol (1995) 483:67–78. doi:10.1113/jphysiol.1995.sp020568

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Cohen CJ, McCarthy RT, Barrett PQ, Rasmussen H. Ca channels in adrenal glomerulosa cells: K⁺ and angiotensin II increase T-type Ca channel current. Proc Natl Acad Sci U S A (1988) 85:2412–6. doi:10.1073/pnas.85.7.2412

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Lotshaw DP. Role of membrane depolarization and T-type Ca²⁺ channels in angiotensin II and K⁺ stimulated aldosterone secretion. Mol Cell Endocrinol (2001) 175:157–71. doi:10.1016/S0303-7207(01)00384-7

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Payet MD, Durroux T, Bilodeau L, Guillon G, Gallo-Payet N. Characterization of K⁺ and Ca²⁺ ionic currents in glomerulosa cells from human adrenal glands. Endocrinology (1994) 134:2589–98. doi:10.1210/endo.134.6.7515004

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Makara JK, Petheo GL, Tóth A, Spät A. Effect of osmolarity on aldosterone production by rat adrenal glomerulosa cells. Endocrinology (2000) 141:1705–10. doi:10.1210/endo.141.5.7465

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Makara JK, Koncz P, Petheo GL, Spät A. Role of cell volume in K⁺-induced Ca²⁺ signaling by rat adrenal glomerulosa cells. Endocrinology (2003) 144:4916–22. doi:10.1210/en.2003-0383

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Braley LM, Williams GH. Rat adrenal cell sensitivity to angiotensin II, alpha-1-24-ACTH, and potassium: a comparative study. Am J Physiol (1977) 233:E402–6.

PubMed Abstract | Google Scholar

24. Spät A. Glomerulosa cell-a unique sensor of extracellular K⁺ concentration. Mol Cell Endocrinol (2004) 217:23–6. doi:10.1016/j.mce.2003.10.046

CrossRef Full Text | Google Scholar

25. Czirják G, Fischer T, Spät A, Lesage F, Enyedi P. TASK (TWIK-related acid-sensitive K⁺ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II. Mol Endocrinol (2000) 14:863–74. doi:10.1210/mend.14.6.0466

CrossRef Full Text | Google Scholar

26. Czirják G, Enyedi P. TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells. Mol Endocrinol (2002) 16:621–9. doi:10.1210/me.16.3.621

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Quinn SJ, Cornwall MC, Williams GH. Electrical properties of isolated rat adrenal glomerulosa and fasciculata cells. Endocrinology (1987) 120:903–14. doi:10.1210/endo-120-3-903

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Velarde-Miranda C, Gomez-Sanchez EP, Gomez-Sanchez CE. Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel. Clin Exp Pharmacol Physiol (2013) 40(12):895–901. doi:10.1111/1440-1681.12151

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Schrier AD, Wang H, Talley EM, Perez-Reyes E, Barrett PQ. alpha1H T-type Ca²⁺ channel is the predominant subtype expressed in bovine and rat zona glomerulosa. Am J Physiol Cell Physiol (2001) 280:C265–72.

PubMed Abstract | Google Scholar

30. Hu C, Rusin CG, Tan Z, Guagliardo NA, Barrett PQ. Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. J Clin Invest (2012) 122(6):2046–53. doi:10.1172/JCI61996

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Várnai P, Petheö GL, Makara JK, Spät A. Electrophysiological study on the high K⁺ sensitivity of rat glomerulosa cells. Pflügers Arch (1998) 435:429–31. doi:10.1007/s004240050534

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Barrett PQ, Ertel EA, Smith MM, Nee JJ, Cohen CJ. Voltage-gated calcium currents have two opposing effects on the secretion of aldosterone. Am J Physiol Cell Physiol (1995) 268:C985–92.

PubMed Abstract | Google Scholar

33. Lu HK, Fern RJ, Luthin D, Linden J, Liu LP, Cohen CJ, et al. Angiotensin II stimulates T-type Ca²⁺ channel currents via activation of a G protein, G_i. Am J Physiol Cell Physiol (1996) 271:C1340–9.

PubMed Abstract | Google Scholar

34. Cherradi N, Pardo B, Greenberg AS, Kraemer FB, Capponi AM. Angiotensin II activates cholesterol ester hydrolase in bovine adrenal glomerulosa cells through phosphorylation mediated by p42/p44 mitogen-activated protein kinase. Endocrinology (2003) 144:4905–15. doi:10.1210/en.2003-0325

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Cherradi N, Brandenburger Y, Capponi AM. Mitochondrial regulation of mineralocorticoid biosynthesis by calcium and the StAR protein. Eur J Endocrinol (1998) 139:249–56. doi:10.1530/eje.0.1390249

CrossRef Full Text | Google Scholar

36. Clark BJ, Combs R. Angiotensin II and cyclic adenosine 3’,5’-monophosphate induce human steroidogenic acute regulatory protein transcription through a common steroidogenic factor-1 element. Endocrinology (1999) 140:4390–8. doi:10.1210/en.140.10.4390

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Capponi AM. The control by angiotensin II of cholesterol supply for aldosterone biosynthesis. Mol Cell Endocrinol (2004) 217:113–8. doi:10.1016/j.mce.2003.10.055

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Whitebread S, Mele M, Kamber B, De Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun (1989) 163:284–91. doi:10.1016/0006-291X(89)92133-5

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Balla T, Baukal AJ, Eng S, Catt KJ. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Mol Pharmacol (1991) 40:401–6.

PubMed Abstract | Google Scholar

40. Hajnóczky G, Csordás G, Bagó A, Chiu AT, Spät A. Angiotensin II exerts its effect on aldosterone production and potassium permeability through receptor subtype AT₁ in rat adrenal glomerulosa cells. Biochem Pharmacol (1992) 43:1009–12. doi:10.1016/0006-2952(92)90606-J

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Enyedi P, Büki B, Mucsi I, Spät A. Polyphosphoinositide metabolism in adrenal glomerulosa cells. Mol Cell Endocrinol (1985) 41:105–12. doi:10.1016/0303-7207(85)90147-9

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Rossier MF, Capponi AM, Vallotton MB. Inositol trisphosphate isomers in angiotensin II-stimulated adrenal glomerulosa cells. Mol Cell Endocrinol (1988) 57:163–8. doi:10.1016/0303-7207(88)90071-8

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Baukal AJ, Balla T, Hunyady L, Hausdorff W, Guillemette G, Catt KJ. Angiotensin II and guanine nucleotides stimulate formation of inositol 1,4,5-trisphosphate and its metabolites in permeabilized adrenal glomerulosa cells. J Biol Chem (1988) 263:6087–92.

PubMed Abstract | Google Scholar

44. Baukal AJ, Guillemette G, Rubin R, Spät A, Catt KJ. Binding sites for inositol trisphosphate in the bovine adrenal cortex. Biochem Biophys Res Commun (1985) 133:532–8. doi:10.1016/0006-291X(85)90939-8

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Guillemette G, Balla T, Baukal AJ, Spät A, Catt KJ. Intracellular receptors for inositol 1,4,5-trisphosphate in angiotensin II target tissues. J Biol Chem (1987) 262:1010–5.

PubMed Abstract | Google Scholar

46. Spät A, Bradford PG, McKinney JS, Rubin RP, Putney JW Jr. A saturable receptor for ³²P-inositol-1,4,5-triphosphate in hepatocytes and neutrophils. Nature (1986) 319:514–6. doi:10.1038/319514a0

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Enyedi P, Szabadkai G, Horváth A, Szilágyi L, Gráf L, Spät A. Inositol 1,4,5-trisphosphate receptor subtypes in adrenal glomerulosa cells. Endocrinology (1994) 134:2354–9. doi:10.1210/en.134.6.2354

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Hunyady L, Rohács T, Bagó A, Deák F, Spät A. Dihydropyridine-sensitive initial component of the ANG II-induced Ca²⁺ response in rat adrenal glomerulosa cells. Am J Physiol Cell Physiol (1994) 266:C67–72.

PubMed Abstract | Google Scholar

49. Kramer RE. Angiotensin II-stimulated changes in calcium metabolism in cultured glomerulosa cells. Mol Cell Endocrinol (1988) 60:199–210. doi:10.1016/0303-7207(88)90179-7

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Burnay MM, Python CP, Vallotton MB, Capponi AM, Rossier MF. Role of the capacitative calcium influx in the activation of steroidogenesis by angiotensin-II in adrenal glomerulosa cells. Endocrinology (1994) 135:751–8. doi:10.1210/en.135.2.751

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Rohács T, Bagó A, Deák F, Hunyady L, Spät A. Capacitative Ca²⁺ influx in adrenal glomerulosa cells. Possible role in angiotensin II response. Am J Physiol (1994) 267:C1246–52.

PubMed Abstract | Google Scholar

52. Rossier MF, Aptel HBC, Python CP, Burnay MM, Vallotton MB, Capponi AM. Inhibition of low threshold calcium channels by angiotensin II in adrenal glomerulosa cells through activation of protein kinase. J Biol Chem (1995) 270:15137–42. doi:10.1074/jbc.270.25.15137

CrossRef Full Text | Google Scholar

53. Hajnóczky G, Csordás G, Hunyady L, Kalapos MP, Balla T, Enyedi P, et al. Angiotensin-II inhibits Na⁺/K⁺ pump in rat adrenal glomerulosa cells: possible contribution to stimulation of aldosterone production. Endocrinology (1992) 130:1637–44. doi:10.1210/endo.130.3.1311245

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Lopes CM, Rohacs T, Czirjak G, Balla T, Enyedi P, Logothetis DE. PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K⁺ channels. J Physiol (2005) 564:117–29. doi:10.1113/jphysiol.2004.081935

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Maturana AD, Casal AJ, Demaurex N, Vallotton MB, Capponi AM, Rossier MF. Angiotensin II negatively modulates L-type calcium channels through a pertussis toxin-sensitive G protein in adrenal glomerulosa cells. J Biol Chem (1999) 274:19943–8. doi:10.1074/jbc.274.28.19943

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Balla T, Holló Z, Várnai P, Spät A. Angiotensin II inhibits potassium-induced calcium signal generation in rat adrenal glomerulosa cells. Biochem J (1991) 273:399–404. doi:10.1042/bj2730399

CrossRef Full Text | Google Scholar

57. Cirillo M, Quinn SJ, Canessa ML. Early and late effects of angiotensin-II on Ca²⁺ fluxes in bovine adrenal zona glomerulosa cells. Endocrinology (1993) 132:1921–30. doi:10.1210/en.132.5.1921

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Enyedi P, Mucsi I, Hunyady L, Catt KJ, Spät A. The role of guanyl nucleotide binding proteins in the formation of inositol phosphates in adrenal glomerulosa cells. Biochem Biophys Res Commun (1986) 140:941–7. doi:10.1016/0006-291X(86)90726-6

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Enyeart JJ. Biochemical and Ionic signaling mechanisms for ACTH-stimulated cortisol production. Vitam Horm (2005) 70:265–9. doi:10.1016/S0083-6729(05)70008-X

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Matthews EK, Saffran M. Ionic dependence of adrenal steroidogenesis and ACTH-induced changes in the membrane potential of adrenocortical cells. J Physiol (1973) 234:43–64. doi:10.1113/jphysiol.1973.sp010333

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Lymangrover JR, Matthews EK, Saffran M. Membrane potential changes of mouse adrenal zona fasciculata cells in response to adrenocorticotropin and adenosine 3’,5’-monophosphate. Endocrinology (1982) 110:462–8. doi:10.1210/endo-110-2-462

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Enyeart JJ, Enyeart JA. Adrenal fasciculata cells express T-type and rapidly and slowly activating L-type Ca²⁺ channels that regulate cortisol secretion. Am J Physiol Cell Physiol (2015) 308:C899–918. doi:10.1152/ajpcell.00002.2015

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Enyeart JJ, Danthi SJ, Liu H, Enyeart JA. Angiotensin II inhibits bTREK-1 K⁺ channels in adrenocortical cells by separate Ca²⁺- and ATP hydrolysis-dependent mechanisms. J Biol Chem (2005) 280:30814–28. doi:10.1074/jbc.M504283200

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Enyeart JA, Danthi SJ, Enyeart JJ. TREK-1 K⁺ channels couple angiotensin II receptors to membrane depolarization and aldosterone secretion in bovine adrenal glomerulosa cells. Am J Physiol Endocrinol Metab (2004) 287:E1154–65. doi:10.1152/ajpendo.00223.2004

PubMed Abstract | CrossRef Full Text | Google Scholar

65. Naville D, Lebrethon MC, Kermabon AY, Rouer E, Benarous R, Saez JM. Characterization and regulation of the angiotensin II type-1 receptor (binding and mRNA) in human adrenal fasciculata-reticularis cells. FEBS Lett (1993) 321:184–8. doi:10.1016/0014-5793(93)80104-3

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Dell GC, Morley SD, Mullins JJ, Williams BC, Walker SW. Multiple signal transduction systems regulate angiotensin II type 1 (AT1) receptor mRNA expression in bovine adrenocortical cells. Endocr Res (1996) 22:363–8.

PubMed Abstract | Google Scholar

67. Bird IM, Magness RR, Mason JI, Rainey WE. Angiotensin-II acts via the type 1 receptor to inhibit 17 alpha-hydroxylase cytochrome P450 expression in ovine adrenocortical cells. Endocrinology (1992) 130:3113–21. doi:10.1210/endo.130.6.1317775

PubMed Abstract | CrossRef Full Text | Google Scholar

68. Bird IM, Williams BC, Walker SW. Identification and metabolism of phosphoinositol species formed on angiotensin II stimulation of zona fasciculata-reticularis cells from the bovine adrenal cortex. Mol Cell Endocrinol (1992) 83:29–38. doi:10.1016/0303-7207(92)90192-9

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Burnay MM, Vallotton MB, Capponi AM, Rossier MF. Angiotensin II potentiates adrenocorticotropic hormone-induced cAMP formation in bovine adrenal glomerulosa cells through a capacitative calcium influx. Biochem J (1998) 330:21–7. doi:10.1042/bj3300021

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Trnka P, Orellana L, Walsh M, Pool L, Borzi P. Reninoma: an uncommon cause of Renin-mediated hypertension. Front Pediatr (2014) 2:89. doi:10.3389/fped.2014.00089

PubMed Abstract | CrossRef Full Text | Google Scholar

71. Aguilar F, Lo M, Claustrat B, Saez JM, Sassard J, Li JY. Hypersensitivity of the adrenal cortex to trophic and secretory effects of angiotensin II in Lyon genetically-hypertensive rats. Hypertension (2004) 43:87–93. doi:10.1161/01.HYP.0000107194.44040.d4

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Healy DP, Maciejewski AR, Printz MP. Autoradiographic localization of [125I]-angiotensin II binding sites in the rat adrenal gland. Endocrinology (1985) 116:1221–3. doi:10.1210/endo-116-3-1221

PubMed Abstract | CrossRef Full Text | Google Scholar

73. Lehoux JG, Bird IM, Briere N, Martel D, Ducharme L. Influence of dietary sodium restriction on angiotensin II receptors in rat adrenals. Endocrinology (1997) 138:5238–47. doi:10.1210/endo.138.12.5612

PubMed Abstract | CrossRef Full Text | Google Scholar

74. Whitley GSJ, Hyatt PJ, Tait JF. Angiotensin II-induced inositol phosphate production in isolated rat zona glomerulosa and fasciculata/reticularis cells. Steroids (1987) 49:271–86. doi:10.1016/0039-128X(87)90004-3

PubMed Abstract | CrossRef Full Text | Google Scholar

75. Braley LM, Menachery AI, Brown EM, Williams GH. Comparative effect of angiotensin II, potassium, adrenocorticotropin, and cyclic adenosine 3’,5’-monophosphate on cytosolic calcium in rat adrenal cells. Endocrinology (1986) 119:1010–9. doi:10.1210/endo-119-3-1010

PubMed Abstract | CrossRef Full Text | Google Scholar

76. Parmar J, Key RE, Rainey WE. Development of an adrenocorticotropin-responsive human adrenocortical carcinoma cell line. J Clin Endocrinol Metab (2008) 93:4542–6. doi:10.1210/jc.2008-0903

PubMed Abstract | CrossRef Full Text | Google Scholar

77. Rossier MF, Lesouhaitier O, Perrier E, Bockhorn L, Chiappe A, Lalevee N. Aldosterone regulation of T-type calcium channels. J Steroid Biochem Mol Biol (2003) 85:383–8. doi:10.1016/S0960-0760(03)00201-2

PubMed Abstract | CrossRef Full Text | Google Scholar

78. Szanda G, Koncz P, Várnai P, Spät A. Mitochondrial Ca²⁺ uptake with and without the formation of high-Ca²⁺ microdomains. Cell Calcium (2006) 40:527–38. doi:10.1016/j.ceca.2006.08.019

PubMed Abstract | CrossRef Full Text | Google Scholar

79. Kim YH, Park TJ, Lee YH, Baek KJ, Suh PG, Ryu SH, et al. Phospholipase C-delta1 is activated by capacitative calcium entry that follows phospholipase C-beta activation upon bradykinin stimulation. J Biol Chem (1999) 274:26127–34. doi:10.1074/jbc.274.37.26127

PubMed Abstract | CrossRef Full Text | Google Scholar

80. Biden TJ, Altin JG, Karjalainen A, Bygrave FL. Stimulation of hepatic inositol 1,4,5-trisphosphate kinase activity by Ca²⁺-dependent and -independent mechanisms. Biochem J (1988) 256:697–701. doi:10.1042/bj2560697

PubMed Abstract | CrossRef Full Text | Google Scholar

81. Balla T, Baukal AJ, Guillemette G, Catt KJ. Multiple pathways of inositol polyphosphate metabolism in angiotensin-stimulated adrenal glomerulosa cells. J Biol Chem (1988) 263:4083–91.

PubMed Abstract | Google Scholar

82. Rossier MF, Dentand IA, Lew PD. Interconversion of inositol (1,4,5)-trisphosphate to inositol (1, 3,4,5)-tetrakisphosphate and (1,3,4)-trisphosphate in permeabilized adrenal glomerulosa cells is calcium-sensitive and ATP-dependent. Biochem Biophys Res Commun (1986) 139:259–65. doi:10.1016/S0006-291X(86)80107-3

PubMed Abstract | CrossRef Full Text | Google Scholar

83. Spät A, Fabiato A, Rubin RP. Binding of inositol trisphosphate by a liver microsomal fraction. Biochem J (1986) 233:929–32. doi:10.1042/bj2330929

PubMed Abstract | CrossRef Full Text | Google Scholar

84. Poirier SN, Poitras M, Chorvatova A, Payet MD, Guillemette G. FK506 blocks intracellular Ca²⁺ oscillations in bovine adrenal glomerulosa cells. Biochemistry (2001) 40:6486–92. doi:10.1021/bi010207k

PubMed Abstract | CrossRef Full Text | Google Scholar

85. Carafoli E. Calcium pump of the plasma membrane. Physiol Rev (1991) 71:129–53.

Google Scholar

86. Netticadan T, Kato K, Tappia P, Elimban V, Dhalla NS. Phosphorylation of cardiac Na⁺-K⁺ ATPase by Ca²⁺/calmodulin dependent protein kinase. Biochem Biophys Res Commun (1997) 238:544–8. doi:10.1006/bbrc.1997.7305

PubMed Abstract | CrossRef Full Text | Google Scholar

87. Yingst DR, Davis J, Krenz S, Schiebinger RJ. Insights into the mechanism by which inhibition of Na,K-ATPase stimulates aldosterone production. Metabolism (1999) 48:1167–71. doi:10.1016/S0026-0495(99)90133-6

PubMed Abstract | CrossRef Full Text | Google Scholar

88. Hyatt PJ, Tait JF, Tait SAS. The mechanism of the effect of K⁺ on the steroidogenesis of rat zona glomerulosa cells of the adrenal cortex: role of cyclic AMP. Proc R Soc Lond B Biol Sci (1986) 227:21–42. doi:10.1098/rspb.1986.0007

PubMed Abstract | CrossRef Full Text | Google Scholar

89. Kojima I, Kojima K, Rasmussen H. Intracellular calcium and adenosine 3’,5’-cyclic monophosphate as mediators of potassium-induced aldosterone secretion. Biochem J (1985) 228:69–76. doi:10.1042/bj2280069

PubMed Abstract | CrossRef Full Text | Google Scholar

90. Spät A. Stimulus-secretion coupling in angiotensin-stimulated adrenal glomerulosa cells. J Steroid Biochem (1988) 29:443–53. doi:10.1016/0022-4731(88)90256-7

PubMed Abstract | CrossRef Full Text | Google Scholar

91. Balla T, Hunyady L, Spät A. Possible role of calcium uptake and calmodulin in adrenal glomerulosa cells: effects of verapamil and trifluoperazine. Biochem Pharmacol (1982) 31:1267–71. doi:10.1016/0006-2952(82)90014-4

PubMed Abstract | CrossRef Full Text | Google Scholar

92. Kojima I, Kojima K, Rasmussen H. Role of calcium and cAMP in the action adrenocorticotropin on aldosterone secretion. J Biol Chem (1985) 260:4248–56.

Google Scholar

93. Begeot M, Langlois D, Penhoat A, Saez JM. Variations in guanine-binding proteins (Gs, Gi) in cultured bovine adrenal cells. Consequences on the effects of phorbol ester and angiotensin II on adrenocorticotropin-induced and cholera-toxin-induced cAMP production. Eur J Biochem (1988) 174:317–21. doi:10.1111/j.1432-1033.1988.tb14100.x

PubMed Abstract | CrossRef Full Text | Google Scholar

94. Marie J, Jard S. Angiotensin II inhibits adenylate cyclase from adrenal cortex glomerulosa zone. FEBS Lett (1983) 159:97–101. doi:10.1016/0014-5793(83)80424-4

PubMed Abstract | CrossRef Full Text | Google Scholar

95. Hausdorff WP, Sekura RD, Aguilera G, Catt KJ. Control of aldosterone production by angiotensin II is mediated by two guanine nucleotide regulatory proteins. Endocrinology (1987) 120:1668–78. doi:10.1210/endo-120-4-1668

PubMed Abstract | CrossRef Full Text | Google Scholar

96. Bell JBG, Tait JF, Tait SAS, Barnes GD, Brown BL. Lack of effect of angiotensin on levels of cyclic AMP in isolated adrenal zona glomerulosa cells from the rat. J Endocrinol (1981) 91:145–54. doi:10.1677/joe.0.0910145

PubMed Abstract | CrossRef Full Text | Google Scholar

97. Woodcock EA, Johnston CI. Inhibition of adenylate cyclase in rat adrenal glomerulosa cells by angiotensin II. Endocrinology (1984) 115:337–41. doi:10.1210/endo-115-1-337

PubMed Abstract | CrossRef Full Text | Google Scholar

98. Katona D, Rajki A, Di BG, Pozzan T, Spät A. Calcium-dependent mitochondrial cAMP production enhances aldosterone secretion. Mol Cell Endocrinol (2015) 412:196–204. doi:10.1016/j.mce.2015.05.002

PubMed Abstract | CrossRef Full Text | Google Scholar

99. Coté M, Guillon G, Payet MD, Gallo-Payet N. Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. J Clin Endocrinol Metab (2001) 86:4495–503. doi:10.1210/jcem.86.9.7837

PubMed Abstract | CrossRef Full Text | Google Scholar

100. Cooper DM, Tabbasum VG. Adenylate cyclase-centred microdomains. Biochem J (2014) 462:199–213. doi:10.1042/BJ20140560

PubMed Abstract | CrossRef Full Text | Google Scholar

101. Nishimoto K, Rainey WE, Bollag WB, Seki T. Lessons from the gene expression pattern of the rat zona glomerulosa. Mol Cell Endocrinol (2013) 371:107–13. doi:10.1016/j.mce.2012.12.023

PubMed Abstract | CrossRef Full Text | Google Scholar

102. Shen T, Suzuki Y, Poyard M, Best-Belpomme M, Defer N, Hanoune J. Localization and differential expression of adenylyl cyclase messenger ribonucleic acids in rat adrenal gland determined by in situ hybridization. Endocrinology (1997) 138:4591–8. doi:10.1210/en.138.11.4591

PubMed Abstract | CrossRef Full Text | Google Scholar

103. Willoughby D, Cooper DM. Organization and Ca²⁺ regulation of adenylyl cyclases in cAMP microdomains. Physiol Rev (2007) 87:965–1010. doi:10.1152/physrev.00049.2006

PubMed Abstract | CrossRef Full Text | Google Scholar

104. Tremblay E, Payet MD, Gallo-Payet N. Effects of ACTH and angiotensin II on cytosolic calcium in cultured adrenal glomerulosa cells. Role of cAMP production in the ACTH effect. Cell Calcium (1991) 12:655–73. doi:10.1016/0143-4160(91)90036-E

PubMed Abstract | CrossRef Full Text | Google Scholar

105. Gallo-Payet N, Grazzini E, Coté M, Chouinard L, Chorvatova A, Bilodeau L, et al. Role of Ca²⁺ in the action of adrenocorticotropin in cultured human adrenal glomerulosa cells. J Clin Invest (1996) 98:460–6. doi:10.1172/JCI118812

PubMed Abstract | CrossRef Full Text | Google Scholar

106. Fülöp L, Rajki A, Katona D, Szanda G, Spät A. Extramitochondrial OPA1 and adrenocortical function. Mol Cell Endocrinol (2013) 381:70–9. doi:10.1016/j.mce.2013.07.021

PubMed Abstract | CrossRef Full Text | Google Scholar

107. Durroux T, Gallo-Payet N, Payet MD. Effects of adrenocorticotropin on action potential and calcium currents in cultured rat and bovine glomerulosa cells. Endocrinology (1991) 129:2139–47. doi:10.1210/endo-129-4-2139

PubMed Abstract | CrossRef Full Text | Google Scholar

108. Lenglet S, Louiset E, Delarue C, Vaudry H, Contesse V. Activation of 5-HT(7) receptor in rat glomerulosa cells is associated with an increase in adenylyl cyclase activity and calcium influx through T-type calcium channels. Endocrinology (2002) 143:1748–60. doi:10.1210/endo.143.5.8817

PubMed Abstract | CrossRef Full Text | Google Scholar

109. Hunyady L, Balla T, Nagy K, Spät A. Control of phosphatidylinositol turnover in adrenal glomerulosa cells. Biochim Biophys Acta (1982) 713:352–7. doi:10.1016/0005-2760(82)90253-3

PubMed Abstract | CrossRef Full Text | Google Scholar

110. Hajnóczky G, Várnai P, Buday L, Faragó A, Spät A. The role of protein kinase-C in control of aldosterone production by rat adrenal glomerulosa cells: activation of protein kinase-C by stimulation with potassium. Endocrinology (1992) 130:2230–6. doi:10.1210/en.130.4.2230

PubMed Abstract | CrossRef Full Text | Google Scholar

111. Baukal AJ, Hunyady L, Balla T, Ely JA, Catt KJ. Modulation of agonist-induced inositol phosphate metabolism by cyclic adenosine 3’,5’-monophosphate in adrenal glomerulosa cells. Mol Endocrinol (1990) 4:1712–9. doi:10.1210/mend-4-11-1712

PubMed Abstract | CrossRef Full Text | Google Scholar

112. McCarthy RT, Isales CM, Bollag WB, Rasmussen H, Barrett PQ. Atrial natriuretic peptide differentially modulates T- and L-type calcium channels. Am J Physiol (1990) 258:F473–8.

PubMed Abstract | Google Scholar

113. Ganguly A. Atrial natriuretic peptide-induced inhibition of aldosterone secretion: a quest for mediator(s). Am J Physiol Endocrinol Metab (1992) 263:E181–94.

PubMed Abstract | Google Scholar

114. Coté M, Payet MD, Rousseau E, Guillon G, Gallo-Payet N. Comparative involvement of cyclic nucleotide phosphodiesterases and adenylyl cyclase on adrenocorticotropin-induced increase of cyclic adenosine monophosphate in rat and human glomerulosa cells. Endocrinology (1999) 140:3594–601. doi:10.1210/endo.140.8.6889

PubMed Abstract | CrossRef Full Text | Google Scholar

115. MacFarland RT, Zelus BD, Beavo JA. High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. J Biol Chem (1991) 266:136–42.

PubMed Abstract | Google Scholar

116. Nikolaev VO, Gambaryan S, Engelhardt S, Walter U, Lohse MJ. Real-time monitoring of the PDE2 activity of live cells: hormone-stimulated cAMP hydrolysis is faster than hormone-stimulated cAMP synthesis. J Biol Chem (2005) 280:1716–9. doi:10.1074/jbc.C400505200

PubMed Abstract | CrossRef Full Text | Google Scholar

117. Vezzosi D, Bertherat J. Phosphodiesterases in endocrine physiology and disease. Eur J Endocrinol (2011) 165:177–88. doi:10.1530/EJE-10-1123

PubMed Abstract | CrossRef Full Text | Google Scholar

118. Fredlund P, Saltman S, Kondo T, Douglas J, Catt KJ. Aldosterone production by isolated glomerulosa cells: modulation of sensitivity to angiotensin II and ACTH by extracellular potassium concentration. Endocrinology (1977) 100:481–6. doi:10.1210/endo-100-2-481

PubMed Abstract | CrossRef Full Text | Google Scholar

119. Hajnóczky G, Várnai P, Holló Z, Christensen SB, Balla T, Enyedi P, et al. Thapsigargin-induced increase in cytoplasmic Ca²⁺ concentration and aldosterone production in rat adrenal glomerulosa cells: interaction with potassium and angiotensin-II. Endocrinology (1991) 128:2639–44. doi:10.1210/endo-128-5-2639

PubMed Abstract | CrossRef Full Text | Google Scholar

120. Pratt JH, Rothrock JK, Dominguez JH. Evidence that angiotensin-II and potassium collaborate to increase cytosolic calcium and stimulate the secretion of aldosterone. Endocrinology (1989) 125:2463–9. doi:10.1210/endo-125-5-2463

PubMed Abstract | CrossRef Full Text | Google Scholar

121. Spät A, Balla I, Balla T, Enyedi P, Hajnóczky G, Rohács T. Sustained stimulation of aldosterone production by angiotensin II is potentiated by nickel. Am J Physiol Endocrinol Metab (1990) 258:E555–61.

PubMed Abstract | Google Scholar

122. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science (2001) 294:333–9. doi:10.1126/science.1063395

PubMed Abstract | CrossRef Full Text | Google Scholar

123. Kar P, Nelson C, Parekh AB. Selective activation of the transcription factor NFAT1 by calcium microdomains near Ca²⁺ release-activated Ca²⁺ (CRAC) channels. J Biol Chem (2011) 286:14795–803. doi:10.1074/jbc.M111.220582

PubMed Abstract | CrossRef Full Text | Google Scholar

124. Balla T, Szebeny M, Kanyár B, Spät A. Angiotensin II and FCCP mobilizes calcium from different intracellular pools in adrenal glomerulosa cells; analysis of calcium fluxes. Cell Calcium (1985) 6:327–42. doi:10.1016/0143-4160(85)90003-X

PubMed Abstract | CrossRef Full Text | Google Scholar

125. Balla T, Enyedi P, Hunyady L, Spät A. Effects of lithium on angiotensin-stimulated phosphatidylinositol turnover and aldosterone production in adrenal glomerulosa cells: a possible causal relationship. FEBS Lett (1984) 171:179–82. doi:10.1016/0014-5793(84)80483-4

PubMed Abstract | CrossRef Full Text | Google Scholar

126. Xing Y, Parker CR, Edwards M, Rainey WE. ACTH is a potent regulator of gene expression in human adrenal cells. J Mol Endocrinol (2010) 45:59–68. doi:10.1677/JME-10-0006

PubMed Abstract | CrossRef Full Text | Google Scholar

127. Nogueira EF, Xing Y, Morris CA, Rainey WE. Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis. J Mol Endocrinol (2009) 42:319–30. doi:10.1677/JME-08-0112

PubMed Abstract | CrossRef Full Text | Google Scholar

128. Howard B, Wang Y, Xekouki P, Faucz FR, Jain M, Zhang L, et al. Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas. J Clin Endocrinol Metab (2014) 99:E536–43. doi:10.1210/jc.2013-3495

PubMed Abstract | CrossRef Full Text | Google Scholar

129. Pihlajoki M, Dorner J, Cochran RS, Heikinheimo M, Wilson DB. Adrenocortical zonation, renewal, and remodeling. Front Endocrinol (2015) 6:27. doi:10.3389/fendo.2015.00027

PubMed Abstract | CrossRef Full Text | Google Scholar

130. Drelon C, Berthon A, Mathieu M, Martinez A, Val P. Adrenal cortex tissue homeostasis and zonation: a WNT perspective. Mol Cell Endocrinol (2015) 408:156–64. doi:10.1016/j.mce.2014.12.014

PubMed Abstract | CrossRef Full Text | Google Scholar

131. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC, Rainey WE. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol (1997) 11:638–49. doi:10.1210/mend.11.5.9920

PubMed Abstract | CrossRef Full Text | Google Scholar

132. Shanmughapriya S, Rajan S, Hoffman NE, Zhang X, Guo S, Kolesar JE, et al. Ca²⁺ signals regulate mitochondrial metabolism by stimulating CREB-mediated expression of the mitochondrial Ca²⁺ uniporter gene MCU. Sci Signal (2015) 8:ra23. doi:10.1126/scisignal.2005673

PubMed Abstract | CrossRef Full Text | Google Scholar

133. Doi M, Satoh F, Maekawa T, Nakamura Y, Fustin JM, Tainaka M, et al. Isoform-specific monoclonal antibodies against 3beta-hydroxysteroid dehydrogenase/isomerase family provide markers for subclassification of human primary aldosteronism. J Clin Endocrinol Metab (2014) 99:E257–62. doi:10.1210/jc.2013-3279

CrossRef Full Text | Google Scholar

134. Yarimizu D, Doi M, Ota T, Okamura H. Stimulus-selective induction of the orphan nuclear receptor NGFIB underlies different influences of angiotensin II and potassium on the human adrenal gland zona glomerulosa-specific 3beta-HSD isoform gene expression in adrenocortical H295R cells. Endocr J (2015) 62:765–76. doi:10.1507/endocrj.EJ15-0211

CrossRef Full Text | Google Scholar

135. Bassett MH, Suzuki T, Sasano H, White PC, Rainey WE. The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol (2004) 18:279–90. doi:10.1210/me.2003-0005

PubMed Abstract | CrossRef Full Text | Google Scholar

136. Nogueira EF, Rainey WE. Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. Endocrinology (2010) 151:1060–70. doi:10.1210/en.2009-0977

PubMed Abstract | CrossRef Full Text | Google Scholar

137. Szekeres M, Turu G, Orient A, Szalai B, Supeki K, Cserzo M, et al. Mechanisms of angiotensin II-mediated regulation of aldosterone synthase expression in H295R human adrenocortical and rat adrenal glomerulosa cells. Mol Cell Endocrinol (2009) 302:244–53. doi:10.1016/j.mce.2008.12.015

PubMed Abstract | CrossRef Full Text | Google Scholar

138. Wang X, Nickenig G, Murphy TJ. The vascular smooth muscle type I angiotensin II receptor mRNA is destabilized by cyclic AMP-elevating agents. Mol Pharmacol (1997) 52:781–7. doi:10.1124/mol.52.5.781

PubMed Abstract | CrossRef Full Text | Google Scholar

139. Wang X, Murphy TJ. Inhibition of cyclic AMP-dependent kinase by expression of a protein kinase inhibitor/enhanced green fluorescent fusion protein attenuates angiotensin II-induced type 1 AT1 receptor mRNA down-regulation in vascular smooth muscle cells. Mol Pharmacol (1998) 54:514–24.

PubMed Abstract | Google Scholar

140. Bird IM, Mason JI, Rainey WE. Hormonal regulation of angiotensin II type 1 receptor expression and AT1-RmRNA levels in human adrenocortical cells. Endocr Res (1995) 21:169–82. doi:10.3109/07435809509030432

PubMed Abstract | CrossRef Full Text | Google Scholar

141. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev (1990) 70:391–425.

Google Scholar

142. Pralong WF, Hunyady L, Várnai P, Wollheim CB, Spät A. Pyridine nucleotide redox state parallels production of aldosterone in potassium-stimulated adrenal glomerulosa cells. Proc Natl Acad Sci U S A (1992) 89:132–6. doi:10.1073/pnas.89.1.132

PubMed Abstract | CrossRef Full Text | Google Scholar

143. Pralong WF, Spät A, Wollheim CB. Dynamic pacing of cell metabolism by intracellular Ca²⁺. J Biol Chem (1994) 269:27310–4.

Google Scholar

144. Rohács T, Nagy G, Spät A. Cytoplasmic Ca²⁺ signalling and reduction of mitochondrial pyridine nucleotides in adrenal glomerulosa cells in response to K⁺, angiotensin II and vasopressin. Biochem J (1997) 322:785–92. doi:10.1042/bj3220785

PubMed Abstract | CrossRef Full Text | Google Scholar

145. Jouaville LS, Pinton P, Bastianutto C, Rutter GA, Rizzuto R. Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. Proc Natl Acad Sci U S A (1999) 96:13807–12. doi:10.1073/pnas.96.24.13807

PubMed Abstract | CrossRef Full Text | Google Scholar

146. Rizzuto R, Simpson AWM, Brini M, Pozzan T. Rapid changes of mitochondrial Ca²⁺ revealed by specifically targeted recombinant aequorin. Nature (1992) 358:325–7. doi:10.1038/358325a0

PubMed Abstract | CrossRef Full Text | Google Scholar

147. Hajnóczky G, Robb-Gaspers LD, Seitz MB, Thomas AP. Decoding of cytosolic calcium oscillations in the mitochondria. Cell (1995) 82:415–24. doi:10.1016/0092-8674(95)90430-1

PubMed Abstract | CrossRef Full Text | Google Scholar

148. Brandenburger Y, Kennedy ED, Python CP, Rossier MF, Vallotton MB, Wollheim CB, et al. Possible role for mitochondrial calcium in angiotensin II- and potassium-stimulated steroidogenesis in bovine adrenal glomerulosa cells. Endocrinology (1996) 137:5544–51. doi:10.1210/endo.137.12.8940382

PubMed Abstract | CrossRef Full Text | Google Scholar

149. Spät A, Pitter JG. The effect of cytoplasmic Ca²⁺ signal on the redox state of mitochondrial pyridine nucleotides. Mol Cell Endocrin (2004) 215:115–8. doi:10.1016/j.mce.2003.11.004

PubMed Abstract | CrossRef Full Text | Google Scholar

150. Kamer KJ, Mootha VK. The molecular era of the mitochondrial calcium uniporter. Nat Rev Mol Cell Biol (2015) 16:545–53. doi:10.1038/nrm4039

PubMed Abstract | CrossRef Full Text | Google Scholar

151. Rizzuto R, Brini M, Murgia M, Pozzan T. Microdomains with high Ca²⁺ close to IP₃-sensitive channels that are sensed by neighboring mitochondria. Science (1993) 262:744–7. doi:10.1126/science.8235595

PubMed Abstract | CrossRef Full Text | Google Scholar

152. Pitter JG, Maechler P, Wollheim CB, Spät A. Mitochondria respond to Ca²⁺ already in the submicromolar range: correlation with redox state. Cell Calcium (2002) 31:97–104. doi:10.1054/ceca.2001.0264

PubMed Abstract | CrossRef Full Text | Google Scholar

153. Rohács T, Tory K, Dobos A, Spät A. Intracellular calcium release is more efficient than calcium influx in stimulating mitochondrial NAD(P)H formation in adrenal glomerulosa cells. Biochem J (1997) 328:525–8. doi:10.1042/bj3280525

PubMed Abstract | CrossRef Full Text | Google Scholar

154. Wiederkehr A, Szanda G, Akhmedov D, Mataki C, Heizmann CW, Schoonjans K, et al. Mitochondrial matrix calcium is an activating signal for hormone secretion. Cell Metab (2011) 13:601–11. doi:10.1016/j.cmet.2011.03.015

PubMed Abstract | CrossRef Full Text | Google Scholar

155. Spät A, Fülöp L, Szanda G. The role of mitochondrial Ca²⁺ and NAD(P)H in the control of aldosterone secretion. Cell Calcium (2012) 52:64–72. doi:10.1016/j.ceca.2012.01.009

CrossRef Full Text | Google Scholar

156. Buck J, Sinclair ML, Schapal L, Cann MJ, Levin LR. Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals. Proc Natl Acad Sci U S A (1999) 96:79–84. doi:10.1073/pnas.96.1.79

PubMed Abstract | CrossRef Full Text | Google Scholar

157. Chen Y, Cann MJ, Litvin TN, Iourgenko V, Sinclair ML, Levin LR, et al. Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science (2000) 289:625–8. doi:10.1126/science.289.5479.625

PubMed Abstract | CrossRef Full Text | Google Scholar

158. Litvin TN, Kamenetsky M, Zarifyan A, Buck J, Levin LR. Kinetic properties of “soluble” adenylyl cyclase. Synergism between calcium and bicarbonate. J Biol Chem (2003) 278:15922–6. doi:10.1074/jbc.M212475200

PubMed Abstract | CrossRef Full Text | Google Scholar

159. Zippin JH, Chen Y, Nahirney P, Kamenetsky M, Wuttke MS, Fischman DA, et al. Compartmentalization of bicarbonate-sensitive adenylyl cyclase in distinct signaling microdomains. FASEB J (2003) 17:82–4.

PubMed Abstract | Google Scholar

160. Acin-Perez R, Salazar E, Kamenetsky M, Buck J, Levin LR, Manfredi G. Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab (2009) 9:265–76. doi:10.1016/j.cmet.2009.01.012

PubMed Abstract | CrossRef Full Text | Google Scholar

161. Di Benedetto G, Scalzotto E, Mongillo M, Pozzan T. Mitochondrial Ca²⁺ uptake induces cyclic AMP generation in the matrix and modulates organelle ATP levels. Cell Metab (2013) 17:965–75. doi:10.1016/j.cmet.2013.05.003

CrossRef Full Text | Google Scholar

162. Berridge MJ. The interaction of cyclic nucleotides and calcium in the control of cell activity. Adv Cyclic Nucl Res (1975) 6:1–98.

Google Scholar